Manipal bid to buyout Medanta for Rs 5800 crore: Report Garima29 April 2019 12:20 PM ISTMUMBAI: Cardiologist Naresh Trehan owned Medanta buyout is likely to conclude as TPG and Temasek-backed Manipal Hospitals has recently submitted a...
Manipal-TPG exclusive agreement period expires; KKR initiates bid for Medanta: Report Garima7 April 2019 4:00 PM ISTMumbai: Joining the fray to get a stake in the Gurugram based Medanta Medicity , US based investor firm KKR recent made a bid According to a recent...
Thermo Fisher to acquire Brammer Bio in 1.7 Billion Dollar deal Garima25 March 2019 12:18 PM ISTThermo Fisher to acquire Brammer Bio in 1.7 Billion Dollar dealUS Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments,...
True North to acquire controlling stake in Max Bupa Health Insurance for Rs 511 crore Garima27 Feb 2019 12:51 PM ISTThe transaction will lead to a cash inflow of Rs 511 crore for Max India. The company intends to utilize the proceeds to invest in both existing and...
TPG-Manipal enter into Exclusive talks to Acquire Medanta- Report Garima17 Feb 2019 10:05 AM ISTMumbai: After losing out on the Fortis deal, the Manipal Group backed by TPG is making moves toward acquiring Gurugram Based Medanta Medicity by...
Fortis Acquisition boils down to TPG verus IHH Ruby Khatun Khatun26 March 2018 5:40 PM ISTNew Delhi: The deal for Fortis seems to be making strides with investors from various angles coming and putting forward their investment strategies....
US employers say CVS-Aetna deal would affect health-benefits decisions: survey Ruby Khatun Khatun20 Dec 2017 9:45 AM ISTNEW YORK: CVS Corp's proposed purchase of Aetna Inc will affect decision-making by a majority of large and mid-size U.S. corporations on employee...
US tribal patent deal could have big impact on generic drug market Ruby Khatun Khatun14 Sept 2017 9:45 AM ISTA groundbreaking deal between Allergan Plc and a Native American tribe to shield the company's patents in administrative proceedings could also be...
GSK bets on pioneering cancer therapy with Adaptimmune deal Ruby Khatun Khatun9 Sept 2017 9:32 AM ISTLONDON: GlaxoSmithKline (GSK) said it has licensed the rights to Adaptimmune's pioneering T-cell therapy program to boost its pipeline in oncology,...
